Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer.

医学 肺癌 肿瘤科 内科学 前瞻性队列研究 靶向治疗 癌症 生殖系 种系突变 突变 基因 生物化学 化学
作者
Justin Jee,Emily S. Lebow,Yonina R. Murciano‐Goroff,Gowtham Jayakumaran,Ronglai Shen,A. Rose Brannon,Ryma Benayed,Azadeh Namakydoust,Michael Offin,Paul K. Paik,Helena A. Yu,Mark T.A. Donoghue,Ahmet Zehir,Alexander Drilon,David B. Solit,David R. Jones,Charles M. Rudin,Michael F. Berger,James M. Isbell,Bob T. Li
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:39 (15_suppl): 9009-9009 被引量:7
标识
DOI:10.1200/jco.2021.39.15_suppl.9009
摘要

9009 Background: The effectiveness of circulating tumor DNA (ctDNA) at matching patients to life prolonging therapy has been studied mostly in small cohorts with limited follow up. The prognostic value of ctDNA alterations, particularly those absent on tissue, is also unclear. To address these questions, we studied survival outcomes in a prospective cohort of patients (N = 1002) with non-small cell lung cancer (NSCLC). Methods: Adults with metastatic or recurrent NSCLC were eligible if they had no known driver mutation or a known driver with progression following targeted therapy. Patients were enrolled at Memorial Sloan Kettering Cancer Center (New York, NY) starting October 21, 2016; analysis here is from a snapshot November 1, 2020. All patients had ctDNA sequenced via the Resolution ctDx Lung platform. To reduce inclusion of incidental germline mutations, we excluded non-functionally significant mutations with an allele frequency 35-65% that were present in gnomAD. Patients could also receive, at their provider’s discretion, tissue sequencing with MSK-IMPACT, which filters germline and clonal hematopoietic (CH) mutations with matched white blood cell sequencing. We performed survival analyses using Cox proportional hazards models from time of diagnosis of advanced disease to death, left truncating at time of study entry. Results: Of 1002 patients, 348 (35%) were treated with targeted therapy; in 181 of these (52%) the targetable alteration was detected in ctDNA. Patients treated with targeted therapy had prolonged survival whether matched by tissue-based methods (HR 0.39, 95%CI 0.30-0.51) or ctDNA (HR 0.47, 95%CI 0.37-0.61). These benefits persisted across multiple subgroups. ctDNA alterations themselves were associated with worse survival (HR 2.2, 95%CI 1.8-2.8), in a manner that scaled with allele fraction and burden. Of 401 patients with time-matched tissue sampling, 62 (15%) had ctDNA alterations that were absent on IMPACT (“unique” ctDNA alterations). Three such patients had unique ctDNA EGFR T790M mutations leading to changes in therapy. However, unique ctDNA alterations were generally associated with worse survival than no ctDNA alterations (HR 2.5, 95%CI 1.7-3.7) and even tissue-matched ctDNA alterations (HR 1.7, 95%CI 1.1-2.4). Of 98 unique ctDNA mutations, 48 (49%) were detectable in tissue at subthreshold levels, 12 (12%) were filtered by IMPACT as CH or germline, and 38 mutations (39%) were absent even at subthreshold levels. ctDNA alteration burden correlated with radiographic disease extent. In multivariate models with radiographic disease extent and other clinical variables, ctDNA alterations were the strongest independent predictor of worse survival. Conclusions: Our results show that ctDNA may match patients to life-prolonging targeted therapy and have prognostic importance. ctDNA may provide data about a patient’s cancer missed by spatially restricted tissue sequencing. Clinical trial information: NCT01775072.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lucas应助pomfret采纳,获得10
刚刚
1秒前
1秒前
科目三应助娇气的天亦采纳,获得10
2秒前
JiangHan发布了新的文献求助10
2秒前
4秒前
GGBOND发布了新的文献求助10
4秒前
5秒前
黄振全发布了新的文献求助10
5秒前
6秒前
Lu发布了新的文献求助10
7秒前
苯氮小羊发布了新的文献求助10
7秒前
hugdoggy发布了新的文献求助10
9秒前
9秒前
英姑应助shawn采纳,获得10
12秒前
完美世界应助22采纳,获得10
12秒前
Hululu完成签到,获得积分10
12秒前
13秒前
精美礼物发布了新的文献求助30
14秒前
anna发布了新的文献求助10
14秒前
GGBOND发布了新的文献求助10
19秒前
pomfret完成签到,获得积分10
19秒前
从容甜瓜完成签到 ,获得积分10
21秒前
量子星尘发布了新的文献求助10
21秒前
22秒前
23秒前
桐桐应助Lu采纳,获得10
24秒前
YWang发布了新的文献求助10
26秒前
han应助归华采纳,获得10
27秒前
27秒前
SYLH应助zly采纳,获得30
30秒前
完美世界应助娇气的天亦采纳,获得10
32秒前
34秒前
37秒前
科目三应助彭栋采纳,获得10
39秒前
方文浩发布了新的文献求助10
39秒前
ding应助YWang采纳,获得10
42秒前
42秒前
林宝雯关注了科研通微信公众号
47秒前
50秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989115
求助须知:如何正确求助?哪些是违规求助? 3531367
关于积分的说明 11253688
捐赠科研通 3269986
什么是DOI,文献DOI怎么找? 1804868
邀请新用户注册赠送积分活动 882078
科研通“疑难数据库(出版商)”最低求助积分说明 809105